Direct And Indirect Cost Of Covid 19 Patients In Iran Pubmed

Direct and indirect cost of COVID-19 patients in Iran - PubMed

Objectives: This study aimed to estimate the cost of COVID-19 patients and some affecting factors in Iran. Methods: This was a prevalence-based cost-of-illness study based on a bottom-up costing approach which was conducted from March 2020 to July 2020.

Direct and indirect cost of COVID-19 patients in Iran - PMC

Nov 8, 2021 The mean cost of productivity lost days due to COVID-19 in patients, and their family caregivers were 4787.682068.32 (PPP) (88% of the total indirect cost), and the mean cost of premature death due to COVID-19 was 662.98332.82 (PPP) (12% of the total indirect cost).

Direct and indirect cost of COVID-19 patients in Iran

Dec 1, 2021 The indirect costs of COVID-19 patients were higher compared to direct costs. The highest mean hospitalization cost of the disease was observed in hoteling. The highest mean outpatient cost of the disease was observed in medicine.

Direct Inpatient Cost and Payments of COVID-19 in Iran: Quantile

Sep 3, 2022 Ghaffari Darab et al. estimated both direct medical and indirect costs of treating COVID-19 from a societal perspective in Iran. Based on their results, COVID-19 cost about 28,240,025,968 Rials in a referral hospital from March to July 2020.

Direct medical cost and cost analysis of COVID-19 in Iran: A

Mar 24, 2022 [ While there is no specific confirmed drug to treat COVID-19, the existing diagnostic tests and supportive interventions impose a high financial burden on health system. Moreover, COVID-19related economic evaluation studies have not been performed till now.

Direct Inpatient Cost and Payments of COVID-19 in Iran - PubMed

Sep 3, 2022 Background: COVID-19 pandemic imposes a substantial medical and socioeconomic burden on health systems. The study aimed to estimate the direct inpatient costs of COVID-19 in Iran. Methods: This is a Cost of Illness (COI) study with the bottom-up method. Provider perspective and prevale

Direct and indirect cost of COVID-19 patients in Iran

Nov 1, 2021 Health promotion perspectives. 2023. TLDR. The incidence of CHE in hospitalized COVID-19 patients was undesirable, which may be due to geographical, economical, and occupational inequalities apart from the factors related to the severity of the disease. 1. Economic Burden of ICU-Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis.

Direct medical cost and cost analysis of COVID-19 in Iran: A - PubMed

Abstract. Background: Although our daily life and economics were severely affected by COVID-19, cost analysis of the disease has not been conducted in Iran. Hence, we aimed to perform a cost analysis study and then estimate direct medical costs of COVID-19.

Direct and indirect cost of COVID-19 patients in Iran

Dec 1, 2021 The mean direct and indirect cost was 3362.49 (PPP, Current International $) (38% of the total cost and 23% of the GDP per capita), and 5450.66 (PPP, Current International $) (62% of the total cost and 37% of the GDP per capita), respectively.

The economic burden of coronavirus disease 2019 (COVID-19): evidence

Data Availability Statement. Go to: Abstract. This study aimed to estimate both direct medical and indirect costs of treating the Coronavirus disease 2019 (COVID-19) from a societal perspective in the patients at a referral hospital in Fars province as well as the economic burden of COVID-19 in Iran in 2020. Methods.

The economic burden of coronavirus disease 2019 (COVID-19 - PubMed

Feb 11, 2021 This study aimed to estimate both direct medical and indirect costs of treating the Coronavirus disease 2019 (COVID-19) from a societal perspective in the patients at a referral hospital in Fars province as well as the economic burden of COVID-19 in Iran in 2020. Methods:

Direct Inpatient Cost and Payments of COVID-19 in Iran: Quantile

The study aimed to estimate the direct inpatient costs of COVID-19 in Iran. Methods: This is a Cost of Illness (COI) study with the bottom-up method. Provider perspective and prevalence approach were applied for cost identification.

Direct and indirect cost of COVID-19 patients in Iran.

Nov 8, 2021 Europe PMC is an archive of life sciences journal literature.

Which patients bring the most costs for hospital? A study on the cost

The median cost of hospitalization in patients was totally 134.48 dollars (Range: 19.192397.54) and respectively 95.87 (Range: 19.19856.63) and 507.30 dollars (Range: 68.942397.54) in patients with hospitalization 9 days and > 9 days.

Costs of inpatient care and out-of-pocket payments for COVID-19

Sep 20, 2023 Abstract. Objective. To identify the costs of hospital care for patients with COVID-19 and the amount of out-of-pocket payments. Methods. We conducted a systematic review using Scopus and WEB OF SCIENCE and PubMed databases in April 5, 2022 and then updated in January 15, 2023.

Frontiers | Editorial: The evolution in pharmacology of infectious

Mar 11, 2024 3 Innovations beyond COVID-19. Moving beyond COVID-19, these years also witnessed significant advancements in the treatment of other infectious diseases. For instance, El-Mahdy et al.s study on chronic hepatitis C patients treated with direct-acting antivirals showed marked improvements in liver function and antioxidant profiles. This work ...

Direct Inpatient Cost and Payments of COVID-19 in Iran: Quantile

Sep 3, 2022 Europe PMC is an archive of life sciences journal literature. https://orcid.org

Diagnostic and Therapeutic Costs of Patients With a Diagnosis of or

Since COVID-19 is a newly emerging disease and there is no definitive cure for the disease, the discovery of an effective medicine may alter medical costs and reduce the hospital length of stay, therefore significantly reducing treatment costs. Keywords: Cost, COVID-19, Iran. Go to: Introduction.

Diagnostic and Therapeutic Costs of Patients With a Diagnosis - PubMed

Diagnostic and Therapeutic Costs of Patients With a Diagnosis of Or Suspected of Coronavirus Disease in Iran. Value Health Reg Issues. 2021 Nov 12;27:21-24. doi: 10.1016/j.vhri.2021.05.001. Online ahead of print. Authors.

Direct medical cost and cost analysis of COVID-19 in Iran: A

Jan 1, 2022 Direct medical cost and cost analysis of COVID-19 in Iran: A multicenter cross-sectional study. - Abstract - Europe PMC. Europe PMC is an archive of life sciences journal literature. Direct medical cost and cost analysis of COVID-19 in Iran: A multicenter cross-sectional study. 1. Europe PMCrequires Javascript to function effectively.

Economic burden of diabetic foot ulcer: a case of Iran

Mar 21, 2024 The majority of the costs are imposed on the age group of 6069 year (53.42% of the productivity lost due to hospital length of stay, 58.91% of the productivity lost due to premature death & 40.41% of direct costs). DFU represents a heavy burden to patients, Irans health system, and the economy.

Cost of Illness of COVID-19 and Its Consequences on Health and Economic

Dec 26, 2022 The direct and indirect costs were estimated to be $1446.06 and $3081.44 per patient. The economic burden for the province and country was estimated to be $43.97 and $2680.88 million. The results showed that the economic burden of this disease particularly premature death costs is remarkably high.

The effect of COVID-19 on public hospital revenues in Iran: An - PubMed

Mar 31, 2022 Method: In this quasi-experimental study, we conducted the interrupted time series analysis to evaluate COVID-19 induced changes in monthly revenues of 18 public hospitals, from April 2018 to August 2021, in Lorestan, Iran.

The effect of COVID-19 on public hospital revenues in Iran: An

Mar 31, 2022 Results. Due to COVID-19, the revenues of public hospitals experienced an average monthly decrease of $172,636 thousand (P-value = 0.01232). For about 13 months, the trend of declining hospital revenues continued.

Related Keywords For Direct And Indirect Cost Of Covid 19 Patients In Iran Pubmed